| |
ASSIST Program
|
,
Phone
:
(877)864-8437
Fax:
|
|
Eligibility
|
| > |
Insurance status will be considered on a case by case status. Patients must meet income requirements that have not been disclosed and must reside and receive treatment in the US. |
| Who Can Apply
|
| > |
Patients must call for a prescreening. |
|
Required
|
| > |
Doctors must provide patients with a prescription and patients must call to enroll. |
|
Supply
|
| > |
Not specified |
|
Ship To
|
| > |
Not specified |
|
Note
|
| > |
For information on Patient Assistance Programs that may be available for United Therapeutics Corporation products (Orenitram®, Remodulin®, Tyvaso®) or Lung Biotechnology's product (Adcirca®), please contact ASSIST at 877 864-8437 |
| |
Includes Support for This Drug
NOTE: Linked drugs are available for Prescribers to Apply Online now.
Click drug logo or drug name to start online application.
|
| Adcirca tablet |
| Orenitram tablet; extended release |
| Remodulin injection |
| Tyvaso solution; inhalation |
| |
| |
|
|